C
Celmatix
Biotech & Life Sciences · New York City, United States · Founded 2009
Harnessing the power of data and genomics to optimize medical decisions about fertility. MoreLess
Celmatix is a biotechnology company focused on advancing women's reproductive health through innovative solutions. Operating in the healthcare and biotechnology market, Celmatix serves patients, healthcare providers, and pharmaceutical companies. The company utilizes genomics and artificial intelligence (AI) to develop treatments for conditions such as ovarian senescence, polycystic ovary syndrome (PCOS), and primary ovarian insufficiency (POI). Celmatix's business model includes partnerships with leading pharmaceutical companies like Bayer and Evotec, as well as funding from organizations such as the Bill & Melinda Gates Foundation. Revenue is generated through collaborative discovery, development, and commercialization of new treatments, as well as through personalized reproductive medicine initiatives. The company collects and analyzes extensive biological and medical data to inform its research and development efforts.
Keywords: biotechnology, reproductive health, genomics, AI, ovarian senescence, PCOS, POI, contraceptive development, partnerships, data analytics.
Company overview
Celmatix company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2009
- Headquarters
- New York City, United States
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 71.3
Valuation & funding
Celmatix funding history
Company financing events and reported valuations.
Growth signals
Celmatix website traffic
Latest recorded traffic for Celmatix is 270 monthly website visits, down 75.5% over the last three months. Celmatix's team declined 18.2% over the past year.
Comparisons
Celmatix compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Celmatix's talent
Source: Dealroom Talent Intelligence.
Investors
1 investor on Celmatix's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Celmatix has talent and traffic
team presence
In the news
Latest news about Celmatix
Recent press, funding announcements, and product moves mentioning Celmatix — open to read from the original sources.
Market sentiment
What the market is saying about Celmatix
An AI-synthesized read of the highest-engagement posts about Celmatix on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Celmatix’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.